Tectonic Therapeutic (TECX) Other Operating Expenses (2023)
Tectonic Therapeutic (TECX) posted quarterly Other Operating Expenses of $83.7 million for Q2 2023, up 490.06% quarter-over-quarter from $14.2 million in Q4 2017.
Analysis
Tectonic Therapeutic (TECX) Other Operating Expenses (2023) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Other Operating Expenses for 2 consecutive years, with $83.7 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Other Operating Expenses changed N/A year-over-year to $83.7 million; the TTM figure through Mar 2024 stood at $83.7 million (changed N/A YoY), while the FY2023 annual figure was $83.7 million, changed N/A from the prior year.
- Other Operating Expenses rose to $83.7 million in Q2 2023 per TECX's latest filing, from $14.2 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $83.7 million in Q2 2023 and bottomed at $83.7 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Tectonic Therapeutic | 569.49 Mn | 569.49 Mn | - |